SEC Form D · Amendment · filed October 24, 2023
Claris Biotherapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Kenneth C. Harrison · Jersey City, NJDirectorClarke Atwell · Jersey City, NJExec · DirectorShehzad Khan · NEW YORK, NYDirectorMeredith C. Fisher · Jersey City, NJDirectorClarke Atwell · Jersey City, NJExec · DirectorLewis Teal · Vancouver, British Columbia, CanadaDirectorVanessa Barrett · Grand Cayman, Cayman IslandsDirectorSunriver Management LLC · Greenwich, CTDirectorReza C. Dana · Jersey City, NJDirectorAndrew T. Basham · Richmond, VADirectorMarc C. De Garidel · Jersey City, NJDirectorS. T. Williams · Richmond, VADirectorLeslie G. Cohen · Boston, MAExec · DirectorMark Floyd · Plano, TXDirectorTerese Gieselman · Vancouver, British Columbia, CanadaDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗